GHRELIN VARIANT AND USES THEREOF

The invention relates to a novel splicing variant of ghrelin/obestatin, called In2-ghrelin, and to the use alone and/or in combination with ghrelin-O-acyltransferase (GOAT) and/or the truncated ghrelin receptor (GHS-R1b), for obtaining useful data in the diagnosis, prognosis and monitoring of breast...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GRACIA NAVARRO, FRANCISCO, KINEMAN, RHONDA DENISSE, BENITO LOPEZ, PEDRO, CASTANO FUENTES, JUSTO PASTOR, LUQUE HUERTAS, RAUL MIGUEL, GAHETE ORTIZ, MANUEL DAVID, MARTINEZ FUENTES, ANTONIO JESUS, CORDOBA CHACON, JOSE
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a novel splicing variant of ghrelin/obestatin, called In2-ghrelin, and to the use alone and/or in combination with ghrelin-O-acyltransferase (GOAT) and/or the truncated ghrelin receptor (GHS-R1b), for obtaining useful data in the diagnosis, prognosis and monitoring of breast cancer, hypophysis tumours, and tumours of the ovary, endometrium and cervix. Variante de la ghrelina y sus usos.La presente invención se refiere a una nueva variante de splicing de la ghrelina/obestatina, denominada In2-ghrelina, y a su uso de manera aislada y/o en combinación con la ghrelin-O-aciltransferasa (GOAT) y/o el receptor truncado de ghrelina (GHS-R1b), para la obtención de datos útiles en el diagnóstico, pronóstico y seguimiento del cáncer de mama, de tumores hipofisarios, tumores de ovario, de endometrio y de cérvix.